HCA Healthcare, Inc. $HCA Shares Purchased by LGT Fund Management Co Ltd.

LGT Fund Management Co Ltd. boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 27,420 shares of the company’s stock after acquiring an additional 68 shares during the period. HCA Healthcare accounts for about 0.9% of LGT Fund Management Co Ltd.’s holdings, making the stock its 25th biggest position. LGT Fund Management Co Ltd.’s holdings in HCA Healthcare were worth $10,505,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare during the 1st quarter worth approximately $26,000. Saudi Central Bank acquired a new position in HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC acquired a new position in HCA Healthcare during the 1st quarter worth approximately $27,000. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the 2nd quarter worth approximately $27,000. Finally, Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $28,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. JPMorgan Chase & Co. upped their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a report on Saturday, September 27th. Finally, Bank of America upped their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research note on Wednesday, September 10th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $407.75.

HCA Healthcare Stock Up 0.7%

Shares of HCA Healthcare stock opened at $429.52 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $432.36. The firm has a market cap of $100.50 billion, a PE ratio of 18.05, a P/E/G ratio of 1.34 and a beta of 1.40. The business’s fifty day moving average is $397.53 and its two-hundred day moving average is $372.39.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the company posted $5.50 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.